Interestingly, decreased fasting FGF-19 levels, reflecting impaired intestinal or hepatic FXR signalling, have also been associated with obesity and the development of metabolic-associated fatty liver disease (MAFLD) [30,31]. Here, NR1H4 is linked to obesity due to melanocortin 4 receptor deficiency.